Tempest Therapeutics, Inc. Share Price
TPSTTempest Therapeutics, Inc. Stock Performance
Open $0.97 | Prev. Close N/A | Circuit Range N/A |
Day Range $0.97 - $0.97 | Year Range $0.95 - $12.06 | Volume 100 |
Average Traded $0.97 |
Tempest Therapeutics, Inc. Share Price Chart
About Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.
Tempest Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Jul-26 | $0.96 | $0.96 | +0.00% |
20-Jul-26 | $0.96 | $0.96 | -8.53% |
15-Jul-26 | $1.00 | $1.05 | +7.65% |
14-Jul-26 | $0.97 | $0.98 | -0.71% |
13-Jul-26 | $1.04 | $0.99 | +0.71% |
10-Jul-26 | $0.99 | $0.98 | +1.66% |
09-Jul-26 | $0.96 | $0.96 | -0.62% |
FAQs on Tempest Therapeutics, Inc. Share Price
Can I buy Tempest Therapeutics, Inc. shares in India?
What is the share price of Tempest Therapeutics, Inc.?
What is the 5 year returns of Tempest Therapeutics, Inc.?
What are the high & low stock price of Tempest Therapeutics, Inc. today?
What is the 52-week high and low of Tempest Therapeutics, Inc. stock?